RNA metabolism in neurodegenerative disease
- PMID: 28468937
- PMCID: PMC5451173
- DOI: 10.1242/dmm.028613
RNA metabolism in neurodegenerative disease
Abstract
Aging-related neurodegenerative diseases are progressive and fatal neurological diseases that are characterized by irreversible neuron loss and gliosis. With a growing population of aging individuals, there is a pressing need to better understand the basic biology underlying these diseases. Although diverse disease mechanisms have been implicated in neurodegeneration, a common theme of altered RNA processing has emerged as a unifying contributing factor to neurodegenerative disease. RNA processing includes a series of distinct processes, including RNA splicing, transport and stability, as well as the biogenesis of non-coding RNAs. Here, we highlight how some of these mechanisms are altered in neurodegenerative disease, including the mislocalization of RNA-binding proteins and their sequestration induced by microsatellite repeats, microRNA biogenesis alterations and defective tRNA biogenesis, as well as changes to long-intergenic non-coding RNAs. We also highlight potential therapeutic interventions for each of these mechanisms.
Keywords: Disease; Microsatellite repeats; RNA; RNA binding proteins; lncRNA; miRNA; tRNA.
© 2017. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsThe authors declare no competing or financial interests.
Figures
Similar articles
-
Neurodegeneration and RNA-binding proteins.Wiley Interdiscip Rev RNA. 2017 Mar;8(2). doi: 10.1002/wrna.1394. Epub 2016 Sep 22. Wiley Interdiscip Rev RNA. 2017. PMID: 27659427 Review.
-
RNA processing-associated molecular mechanisms of neurodegenerative diseases.J Appl Genet. 2016 Aug;57(3):323-33. doi: 10.1007/s13353-015-0330-5. Epub 2015 Dec 3. J Appl Genet. 2016. PMID: 26634851 Review.
-
RNA-binding proteins in neurodegeneration: mechanisms in aggregate.Genes Dev. 2017 Aug 1;31(15):1509-1528. doi: 10.1101/gad.304055.117. Genes Dev. 2017. PMID: 28912172 Free PMC article. Review.
-
RNA dysregulation in neurodegenerative diseases.EMBO J. 2025 Feb;44(3):613-638. doi: 10.1038/s44318-024-00352-6. Epub 2025 Jan 9. EMBO J. 2025. PMID: 39789319 Free PMC article. Review.
-
Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.Exp Neurol. 2012 Jun;235(2):469-75. doi: 10.1016/j.expneurol.2012.01.019. Epub 2012 Jan 27. Exp Neurol. 2012. PMID: 22309832 Free PMC article. Review.
Cited by
-
RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis.Int J Mol Sci. 2021 Nov 1;22(21):11870. doi: 10.3390/ijms222111870. Int J Mol Sci. 2021. PMID: 34769301 Free PMC article. Review.
-
Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.Int J Mol Sci. 2020 May 14;21(10):3464. doi: 10.3390/ijms21103464. Int J Mol Sci. 2020. PMID: 32422969 Free PMC article. Review.
-
Long Non-Coding RNAs in Metabolic Organs and Energy Homeostasis.Int J Mol Sci. 2017 Nov 30;18(12):2578. doi: 10.3390/ijms18122578. Int J Mol Sci. 2017. PMID: 29189723 Free PMC article. Review.
-
Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.Int J Mol Sci. 2020 Dec 14;21(24):9500. doi: 10.3390/ijms21249500. Int J Mol Sci. 2020. PMID: 33327559 Free PMC article.
-
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.Nat Commun. 2020 Nov 2;11(1):5540. doi: 10.1038/s41467-020-19264-0. Nat Commun. 2020. PMID: 33139712 Free PMC article.
References
-
- Alami N. H., Smith R. B., Carrasco M. A., Williams L. A., Winborn C. S., Han S. S. W., Kiskinis E., Winborn B., Freibaum B. D., Kanagaraj A. et al. (2014). Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536-543. 10.1016/j.neuron.2013.12.018 - DOI - PMC - PubMed
-
- Antonellis A., Ellsworth R. E., Sambuughin N., Puls I., Abel A., Lee-Lin S.-Q., Jordanova A., Kremensky I., Christodoulou K., Middleton L. T. et al. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293-1299. 10.1086/375039 - DOI - PMC - PubMed
-
- Ash P. E. A., Bieniek K. F., Gendron T. F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., van Blitterswijk M. M., Jansen-West K., Paul J. W., Rademakers R. et al. (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639-646. 10.1016/j.neuron.2013.02.004 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical